Swine vesicular disease (SVD) is a mild, contagious disease with clinical signs that are indistinguishable from those of foot-and-mouth disease. 5, 8 Accurate diagnosis of SVD is therefore important for all countries, particularly those that engage in international trade of live pigs or pork products. The disease was first recognized in Italy in 1966, 8 and has subsequently been reported in several countries within Europe and the Far East. The disease was eradicated from Europe, with the exception of Italy, by the early 1980s, but since 1992, there has been an increase in the incidence of SVD in Europe. 1 The clinical signs of SVD are often mild, and exposure to infection frequently results in subclinical disease characterized by seroconversion without the appearance of clinical disease. 6 For these reasons, eradication campaigns and confirmation of freedom from infection with SVD virus (SVDV) usually involve serological surveillance. In some cases, a retrospective diagnosis of SVD is made based on positive serological results alone. 5 The virus neutralization test (VNT) is considered the definitive assay for the detection of antibodies to SVDV. 4 The require-ment to screen large numbers of sera and to use a test that does not involve the manipulation of live SVD virus led to the development of the monoclonal antibody trapping competition enzyme-linked immunosorbent assay (MAT-ELISA) as previously described. 3 This assay has been extensively validated by the National SVD Reference Laboratories of several member states of the European Union (EU). It is now accepted as the standard screening test for antibodies to SVD virus within the EU 2 and is classified as an alternative to the VNT in the latest version of the Office International des Epizooties manual of standards for diagnostic tests and vaccines. 4 The objective of this study was to further evaluate this assay for use as a test for the detection of antibodies to SVD virus for the purposes of international trade. The intent was to determine the degree of agreement between laboratories in their interpretations of sera as positive or negative for antibody to SVDV rather than to directly assess the sensitivity and specificity of the assays used. Three countries (Canada, Italy, and England) participated in a blind study in which each country assembled a panel of approximately 100 porcine sera. The serum panel from Italy contained field sera (n ϭ 37) from SVD-negative herds (n ϭ 3), field sera (n ϭ 22) from SVD-infected herds (n ϭ 2), genuine positive sera (n ϭ 30) from experimentally infected pigs, and false-positive sera (n ϭ 10) from singleton reactors' herds (n ϭ 10) (i.e., single animals from otherwise negative herds that gave a positive result in serological tests for SVD but were shown never to have had contact with SVDV). The serum panel from England contained field sera (n ϭ 57) from SVD-negative herds, positive sera (n ϭ 37) from pigs infected with 7 different isolates of SVD (Italy 1/ 94, Italy 2/73, UKG 27/72, Poland 1/73, Hong Kong 1/71, Austria 1/73, France 1/73), and sera (n ϭ 2) from pigs infected with foot-and-mouth disease virus. The serum panel from Canada contained field sera (n ϭ 40) from SVD-negative herds and sera (n ϭ 60) from experimentally infected pigs. Canada sent their panel (n ϭ 100) to both Italy and England, while Italy (n ϭ 99) and England (n ϭ 96) sent their panels only to Canada. Each country performed a MAT-ELISA using the 5B7 monoclonal antibody developed and supplied by Dr. E. Brocchi (IZS, Brescia) but with adaptations to the original protocol as developed within each laboratory. The Italian and British MAT-ELISA procedures were essentially the same as described previously, 3 except that the British MAT-ELISA used a cutoff of 70% inhibition as the negative threshold, as opposed to a cutoff of 80% for the Italian MAT-ELISA. The Canadian MAT-ELISA procedure differed from the above by 1) using 100 l/well for all reagent volumes, as opposed to 50 l/well; 2) adding the test sera simultaneously with the conjugated competing monoclonal antibody, as opposed to adding them separately in two steps; 3) using 1 mM ABTS (2,2-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)) dissolved in 0.5 M citrate buffer (pH 4) with 0.015% H 2 O 2 as the hydrogen donor in the colorimetric reaction, as opposed to 0.5 mg/ml orthophenylendiamine in phosphate-citrate buffer (pH 5) with 0.02% H 2 O 2 ; 4) using a final serum dilution of 1/15 as opposed to 1/7.5; and 5) using a cutoff of 50% inhibition, as opposed to 70% or 80%. The results were reported as either positive or negative, and the data are presented in 2 ϫ 2 tables (Tables 1-4) .
The level of agreement on the status of the sera was analyzed by the kappa statistic, which does not assume that any one of the laboratory's results is correct. The kappa statistic provides a measure of the agreement relative to that which is possible beyond chance. Kappa values greater than 0.8 are considered to represent good agreement. 7 The kappa levels of agreement, shown in each table, ranged from 0.83 to 1.0, indicating an excellent agreement between the findings of the 3 laboratories.
Both the Italian and British serum panels contained sera from SVD-naive pigs that had been identified during serological surveys as ''problem sera,'' giving varying degrees of false-positive reactivity in ELISA and/or VNT for antibody to SVDV. This biasing of the samples toward falsepositive reactivity undoubtably lowered the kappa statistic from that which would normally be obtained from a totally random selection of pig sera.
This study indicates that all the MAT-ELISAs using the 5B7 monoclonal antibody are excellent screening tests for the detection of antibodies to SVDV. They can be used very effectively at the herd level to identify positive and negative herds, but discrepancies in the SVDV serological status of an individual animal may arise between laboratories, and the VNT would still need to be used as the definitive test. The ability of these ELISAs to detect sera from pigs exposed to a wide number of SVD isolates indicates the wide specificity of the monoclonal antibody and, therefore, its wide applicability internationally. The MAT-ELISA procedure, although slightly different in each of the 3 laboratories, demonstrated a very high level of agreement in the classification of sera. Rhodococcus equi, which causes pyogranulomatous inflammation in horses and immunosuppressed people, 9,12 has also been described as an uncommon cause of lymphadenitis in cats. 3,5 Reports of R. equi isolation from dogs are sparse. 1, 3, 11 One paper states that R. equi has been recovered from a dog and cites an unpublished source. 5 Another report describes capsular antigens of a number of isolates, including 2 isolates from canine skin and 1 from a canine abscess, but the lesions or clinical signs of these animals are not described. 11 One report states that R. equi was isolated from the feces of 1 farm dog in New Zealand (out of 10 dogs cultured), but it is not stated whether the dog was symptomatic. 1 This report describes a dog with necrotizing pyogranulomatous hepatitis, osteomyelitis, and myositis associated with R. equi.
A 3-month-old female Basenji dog was presented to the referring veterinarian with a history of generalized pain. The dog was from the island of Kona in Hawaii, where the climate is arid. The dog's owners also had horses, but the dog reportedly was never in contact with the horses or with the horse pastures. The dog had been seen several days earlier by another veterinarian and had been treated with amoxicillin, aspirin, and prednisone. On initial examination, the dog was bright and alert but felt pain when touched. Notable dysmetria was evident on the hind end. Radiographs revealed ''mushrooming'' at the physes. The white blood cell count was 36,400 cells/l, including 96% neutrophils. A tentative diagnosis of panosteitis/meningitis was made, and treatment was altered to chloramphenicol, flunixin meglumine, and aspirin. Although the dog initially responded well, it was presented again the next afternoon because it was deteriorating. Cytology of an aspirate from the swollen area on the neck revealed numerous red and white blood cells with bacteria. Enterococcus sp. was cultured at a referring laboratory, and cefadroxil was added to the treatment protocol. The dog initially stabilized, but then started to deteriorate again. On day 9, based on culture results, other antibiotic therapy was discontinued and enrofloxacin was initiated. The dog continued to deteriorate, and died 2 days later. On necropsy, the left scapula and right humerus were crumbly, easily broken, and surrounded by a thick yellow-tan fluid. The liver was irregularly mottled tan and brown. Tan, firm, randomly distributed foci up to 0.5 cm in diameter were scattered throughout the parenchyma of the lungs. Samples of liver, lung, and scapula were fixed in 10% neutral buffered formalin. The bone was demineralized in 14% formic acid. Histologic sections were stained with hematoxylin and eosin (HE), Brown and Hopps Gram stain, periodic acid-Schiff, and Kinyoun's acid-fast stain. Histologically, there was severe multifocal-to-coalescent pyogranulomatous hepatitis, osteomyelitis, myositis, and mild multifocal pyogranulomatous pneumonia. In some sections of the liver, sheets of inflammatory cells replaced nearly all of the hepatic parenchyma (Fig. 1) . In other sections, the inflammatory cells were arranged in multiple circular aggregates, some randomly distributed and others within portal areas that were markedly expanded by inflammatory cells. The inflammatory cells were a mixture of numerous markedly enlarged epithelioid macrophages and many neutrophils. Occasional multinucleate giant cells were present. A few small aggregates of lymphocytes and plasma cells were mixed among the other inflammatory cells. Numerous intracellular gram-positive coccobacilli were within macrophages (Fig. 2) . Some of the bacteria were short, elongate rods; others formed beaded chains of cocci. The firm, tan foci
